Company / Current Liabilities
10x Genomics, Inc. Current Liabilities History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$153.5M
FY2025
5-year range
$110.4M / $153.5M
FY2021-FY2025
Trend
+30.5%
vs FY2024
Sector context
#116 of 165
Health Care
What the data says
At $153M, 10x Genomics, Inc.'s current liabilities ranks #50 of 165 in the Health Care sector. Current Liabilities returned to growth in FY2025 after 2 years of decline, reaching $153M.
Based on SEC 10-K filings.
$153M in FY2025 with a 5-year CAGR of +5.4%.
Increased from $127M to $153M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +5.4%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
#50 of 165 in Health CareTop 30% of 165This company $153.5M Sector average $4.4B
▼
-96.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.4%, indicating consistent growth.
- In FY2025, current liabilities increased 30.5% year-over-year.
- Ranks #116 out of 165 companies in the Health Care sector.
- Lowest current liabilities in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $153.5M | +30.5% |
| FY2024 | $117.6M | -7.5% |
| FY2023 | $127.2M | -2.9% |
| FY2022 | $131.0M | +18.7% |
| FY2021 | $110.4M | -6.6% |
| FY2020 | $118.1M | +87.4% |
| FY2019 | $63.0M | +94.8% |
| FY2018 | $32.4M | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026